Dr. Penson on Ongoing Research in Prostate Cancer

May 14, 2020
David F. Penson, MD, MPH

Partner | Cancer Centers | <b>Vanderbilt-Ingram Cancer Center</b>

David F. Penson, MD, MPH, MMHC, discusses ongoing research in prostate cancer.

David F. Penson, MD, MPH, MMHC, chair, Department of Urology, and Paul V. Hamilton, MD and Virginia E. Howd Chair, Urologic Oncology, at Vanderbilt University Medical Center, discusses ongoing research in prostate cancer.

Multiple clinical trials are ongoing in prostate cancer currently, says Penson.

For example, the multicenter TRoMbone study is a feasibility trial that is investigating the role of radical prostatectomy in men with oligometastatic disease that has spread to the bone. Additionally, the STAMPEDE trial is planning to open a surgical arm for patients with oligometastatic disease, pending additional funding.

Other clinical trials are exploring the role of checkpoint inhibitors in prostate cancer, explains Penson.

As novel agents and therapeutic modalities continue to be identified, the field of prostate cancer is moving toward becoming a chronic disease and the potential for cure, concludes Penson.